AMG 176


AMG 176 is an MCL-1 inhibitor (myeloid cell leukemia-1) that can prevent cancer cells from creating proteins to protect itself, and can cause cell death.

SparkCures ID 263
Developed By Amgen
Generic Name AMG 176
Treatment Classifications

Clinical Trials


There are no resources, links or videos to display for this treatment.